HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to sarcoidosis: A meta-analysis.

AbstractINTRODUCTION:
The purpose of this study was to examine whether the insertion (I) or deletion (D) of angiotensin-converting enzyme (ACE) polymorphism confers susceptibility to sarcoidosis.
METHODS:
A meta-analysis on the associations between the ACE I/D polymorphism and sarcoidosis was conducted.
RESULTS:
Seventeen comparison studies consisting of 1556 cases and 2381 controls were available for the meta-analysis. Meta-analysis revealed a significant association between the D allele and sarcoidosis (OR 1.206, 95% CI 1.049-1.386, p = 0.009). An ethnicity-specific meta-analysis of the DD+ID genotype showed an association with sarcoidosis in East Asians (OR 1.342, 95% CI 1.041-1.729, p = 0.023). An association was found between the DD genotype of the ACE I/D polymorphism and sarcoidosis (OR 1.251, 95% CI 1.070-1.463, p = 0.005). Furthermore, stratification by ethnicity indicated an association between the DD genotype and sarcoidosis in Europeans (OR = 1.215, 95% CI = 1.010-1.462, p = 0.039).
CONCLUSIONS:
Our meta-analysis demonstrates that the ACE I/D polymorphism is associated with susceptibility to sarcoidosis in European and East Asian populations.
AuthorsGwan Gyu Song, Jae-Hoon Kim, Young Ho Lee
JournalJournal of the renin-angiotensin-aldosterone system : JRAAS (J Renin Angiotensin Aldosterone Syst) Vol. 16 Issue 1 Pg. 219-26 (Mar 2015) ISSN: 1752-8976 [Electronic] England
PMID23676252 (Publication Type: Journal Article, Meta-Analysis, Review)
Copyright© The Author(s) 2013.
Chemical References
  • ACE protein, human
  • Peptidyl-Dipeptidase A
Topics
  • Alleles
  • Gene Deletion
  • Genotype
  • Humans
  • Mutagenesis, Insertional
  • Peptidyl-Dipeptidase A (genetics)
  • Polymorphism, Genetic (genetics)
  • Sarcoidosis (epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: